Want to join the conversation?
Biotechnology company $MDT said that the pricing terms of the cash tender offer by its subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. was up to $3Bil combined aggregate purchase price of certain of CIFSA's and Medtronic, Inc.'s notes. This was up from $2.75Bil as set forth in the Offer to Purchase as on March 31, 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.